These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 21900793)

  • 1. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
    Hossain D; Qian J; Adupe J; Drewnowska K; Bostwick DG
    Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
    Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
    Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
    Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
    Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
    Gammon B; Beilfuss B; Guitart J; Gerami P
    Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features.
    Nardone B; Martini M; Busam K; Marghoob A; West DP; Gerami P
    J Am Acad Dermatol; 2012 Jun; 66(6):917-22. PubMed ID: 21962759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
    Zembowicz A; Yang SE; Kafanas A; Lyle SR
    Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
    Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
    J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
    Senetta R; Paglierani M; Massi D
    Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
    Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
    Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
    Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
    Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
    Fang Y; Dusza S; Jhanwar S; Busam KJ
    Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
    Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
    Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number variations and clinical outcome in atypical spitz tumors.
    Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
    Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma.
    Gammon B; Beilfuss B; Guitart J; Busam KJ; Gerami P
    J Cutan Pathol; 2011 Apr; 38(4):335-41. PubMed ID: 21251038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
    Gerami P; Geraminegad P
    G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
    Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
    Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies.
    Díaz A; Valera A; Carrera C; Hakim S; Aguilera P; García A; Palou J; Puig S; Malvehy J; Alos L
    Am J Surg Pathol; 2011 Nov; 35(11):1733-42. PubMed ID: 21997694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis.
    Martin V; Banfi S; Bordoni A; Leoni-Parvex S; Mazzucchelli L
    Histopathology; 2012 Jan; 60(2):336-46. PubMed ID: 22211292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.
    Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R
    Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.